作者: Claudio Musetti , Marco Quaglia , Tiziana Cena , Michele Battista , Roberta Fenoglio
DOI: 10.1007/S40620-015-0185-1
关键词:
摘要: Background Oral anticoagulation with vitamin K antagonists (VKA) and antiaggregant therapy (AAT) are common among dialysis patients, but it is not known if they increase the risk of hemorrhagic (HE) or cardiovascular events (CVE) in early post-transplant weeks.